Respiratory bronchodilator API supplied with full export documentation for regulated and semi-regulated markets.
C11H14N4O4
STRUCTURAL FORMULADoxofylline API is a widely used respiratory pharmaceutical ingredient indicated for asthma and COPD treatment. Innorex Pharmaceuticals supplies Doxofylline API with complete regulatory documentation support including COA, GMP, DMF, and stability data for regulated and semi-regulated markets including Egypt, Kenya, Myanmar, and other international markets.
| Therapeutic Category | Respiratory / Anti-Asthmatic |
|---|---|
| Mechanism of Action | Doxofylline acts by inhibiting phosphodiesterase activity, resulting in bronchodilation and reduced airway inflammation. |
| Applications | Asthma, COPD, respiratory formulations |
| Test Parameter | Specification | Method |
|---|---|---|
| Appearance | White Powder | Visual |
| Assay | 98.0% - 102.0% | HPLC |
| Loss on Drying | NMT 0.5% | USP |
| Heavy Metals | Complies | USP |
| Residual Solvents | Complies | GC |
Set your Elementor form shortcode under Pharma API Products → APIs: Screen 2.
The availability of this product is subject to the regulatory status of the destination country. Products are not offered or supplied where patented, restricted, or otherwise not permitted under local regulations.